C49.1 Category · further specificity required Malignant neoplasm of connective and soft tissue of upper limb, including shoulder
ICD-10-CM C49.1 identifies “Malignant neoplasm of connective and soft tissue of upper limb, including shoulder” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
No additional notes.
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C49 · Malignant neoplasm of other connective and soft tissue
Includes10
- malignant neoplasm of blood vessel
- malignant neoplasm of bursa
- malignant neoplasm of cartilage
- malignant neoplasm of fascia
- malignant neoplasm of fat
- malignant neoplasm of ligament, except uterine
- malignant neoplasm of lymphatic vessel
- malignant neoplasm of muscle
- malignant neoplasm of synovia
- malignant neoplasm of tendon (sheath)
Excludes 15
Excludes 27
- Kaposi's sarcoma of soft tissue (C46.1)
- malignant neoplasm of heart (C38.0)
- malignant neoplasm of peripheral nerves and autonomic nervous system (C47.-)
- malignant neoplasm of peritoneum (C48.2)
- malignant neoplasm of retroperitoneum (C48.0)
- malignant neoplasm of uterine ligament (C57.3)
- mesothelioma (C45.-)
More specific codes
C49.10Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulderBillable / specificC49.11Malignant neoplasm of connective and soft tissue of right upper limb, including shoulderBillable / specificC49.12Malignant neoplasm of connective and soft tissue of left upper limb, including shoulderBillable / specificOfficial index references
Official index references (13)
Neoplasm, neoplastic (13)
- Neoplasm, neoplastic › aponeurosis › palmarNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › antecubital fossa or spaceNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › armNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › elbowNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › extremity › upperNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › fingerNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › forearmNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › handNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › limb NEC › upperNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › shoulderNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › thumbNeoplasms
- Neoplasm, neoplastic › connective tissue NEC › wristNeoplasms
- Neoplasm, neoplastic › fascia › palmarNeoplasms
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Malignant neoplasm of connective and soft tissue of upper limb, including shoulder
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.